ID   DGKI_RAT                Reviewed;        1050 AA.
AC   F1MAB7; Q810C3; Q810C4; Q810C5;
DT   02-DEC-2020, integrated into UniProtKB/Swiss-Prot.
DT   03-MAY-2011, sequence version 1.
DT   02-OCT-2024, entry version 97.
DE   RecName: Full=Diacylglycerol kinase iota {ECO:0000303|PubMed:15024004};
DE            Short=DAG kinase iota {ECO:0000305|PubMed:15024004};
DE            EC=2.7.1.107 {ECO:0000269|PubMed:15024004};
GN   Name=Dgki {ECO:0000312|RGD:735049};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), FUNCTION (ISOFORMS 2 AND
RP   3), CATALYTIC ACTIVITY (ISOFORM 2), ACTIVITY REGULATION, PATHWAY,
RP   SUBCELLULAR LOCATION (ISOFORMS 2 AND 3), AND TISSUE SPECIFICITY (ISOFORMS
RP   1; 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=15024004; DOI=10.1074/jbc.m312976200;
RA   Ito T., Hozumi Y., Sakane F., Saino-Saito S., Kanoh H., Aoyagi M.,
RA   Kondo H., Goto K.;
RT   "Cloning and characterization of diacylglycerol kinase iota splice variants
RT   in rat brain.";
RL   J. Biol. Chem. 279:23317-23326(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   INTERACTION WITH DLG1; DLG2; DLG3 AND DLG4, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, DEVELOPMENTAL STAGE, AND MOTIF.
RX   PubMed=21119615; DOI=10.1038/emboj.2010.286;
RA   Yang J., Seo J., Nair R., Han S., Jang S., Kim K., Han K., Paik S.K.,
RA   Choi J., Lee S., Bae Y.C., Topham M.K., Prescott S.M., Rhee J.S.,
RA   Choi S.Y., Kim E.;
RT   "DGKiota regulates presynaptic release during mGluR-dependent LTD.";
RL   EMBO J. 30:165-180(2011).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Diacylglycerol kinase that converts diacylglycerol/DAG into
CC       phosphatidic acid/phosphatidate/PA and regulates the respective levels
CC       of these two bioactive lipids (PubMed:15024004). Thereby, acts as a
CC       central switch between the signaling pathways activated by these second
CC       messengers with different cellular targets and opposite effects in
CC       numerous biological processes (Probable). Has probably no preference
CC       for any of the diacylglycerols in terms of the acyl chain composition,
CC       especially for the acyl chain at the sn-2 position (PubMed:15024004).
CC       By controlling the diacylglycerol/DAG-mediated activation of RASGRP3,
CC       negatively regulates the Rap1 signaling pathway. May play a role in
CC       presynaptic diacylglycerol/DAG signaling and control neurotransmitter
CC       release during metabotropic glutamate receptor-dependent long-term
CC       depression (By similarity). {ECO:0000250|UniProtKB:D3YWQ0,
CC       ECO:0000269|PubMed:15024004, ECO:0000305}.
CC   -!- FUNCTION: [Isoform 2]: Has a decreased affinity for ATP and a reduced
CC       diacylglycerol kinase activity. Has no preference for any of the
CC       diacylglycerols in terms of the acyl chain composition.
CC       {ECO:0000269|PubMed:15024004}.
CC   -!- FUNCTION: [Isoform 3]: Has no diacylglycerol kinase activity.
CC       {ECO:0000269|PubMed:15024004}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol + ATP = a 1,2-diacyl-sn-glycero-3-
CC         phosphate + ADP + H(+); Xref=Rhea:RHEA:10272, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:30616, ChEBI:CHEBI:58608,
CC         ChEBI:CHEBI:456216; EC=2.7.1.107;
CC         Evidence={ECO:0000269|PubMed:15024004};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10273;
CC         Evidence={ECO:0000305|PubMed:15024004};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + ATP = 1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:40327, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:52333, ChEBI:CHEBI:74546, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:15024004};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40328;
CC         Evidence={ECO:0000305|PubMed:15024004};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + ATP = 1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:40327, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:52333, ChEBI:CHEBI:74546, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:15024004};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40328;
CC         Evidence={ECO:0000305|PubMed:15024004};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(9Z,12Z)-octadecadienoyl-sn-glycerol + ATP =
CC         1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate +
CC         ADP + H(+); Xref=Rhea:RHEA:40339, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:77097, ChEBI:CHEBI:77098,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:15024004};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40340;
CC         Evidence={ECO:0000305|PubMed:15024004};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=1-octadecanoyl-2-(9Z,12Z)-octadecadienoyl-sn-glycerol + ATP =
CC         1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate +
CC         ADP + H(+); Xref=Rhea:RHEA:40339, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:77097, ChEBI:CHEBI:77098,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:15024004};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40340;
CC         Evidence={ECO:0000305|PubMed:15024004};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
CC         + ATP = 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphate + ADP + H(+); Xref=Rhea:RHEA:40323, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:75728, ChEBI:CHEBI:77091,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:15024004};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40324;
CC         Evidence={ECO:0000305|PubMed:15024004};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
CC         + ATP = 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphate + ADP + H(+); Xref=Rhea:RHEA:40323, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:75728, ChEBI:CHEBI:77091,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:15024004};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40324;
CC         Evidence={ECO:0000305|PubMed:15024004};
CC   -!- ACTIVITY REGULATION: Activated by phosphatidylserine.
CC       {ECO:0000269|PubMed:15024004}.
CC   -!- PATHWAY: Lipid metabolism; glycerolipid metabolism.
CC       {ECO:0000269|PubMed:15024004}.
CC   -!- SUBUNIT: Interacts (via PDZ-binding motif) with DLG4; controls the
CC       localization of DGKI to the synapse (PubMed:21119615). Interacts (via
CC       PDZ-binding motif) with DLG1 (PubMed:21119615). Interacts (via PDZ-
CC       binding motif) with DLG2 (PubMed:21119615). Interacts (via PDZ-binding
CC       motif) with DLG3 (PubMed:21119615). May interact with RASGRP3; involved
CC       in the regulation of RASGRP3 activity (By similarity).
CC       {ECO:0000250|UniProtKB:D3YWQ0, ECO:0000269|PubMed:21119615}.
CC   -!- INTERACTION:
CC       F1MAB7; Q62696: Dlg1; NbExp=3; IntAct=EBI-8523614, EBI-389325;
CC       F1MAB7; Q63622: Dlg2; NbExp=2; IntAct=EBI-8523614, EBI-396947;
CC       F1MAB7; P31016: Dlg4; NbExp=4; IntAct=EBI-8523614, EBI-375655;
CC   -!- SUBCELLULAR LOCATION: Cell projection, axon
CC       {ECO:0000269|PubMed:21119615}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:21119615}. Presynapse
CC       {ECO:0000269|PubMed:21119615}. Postsynapse
CC       {ECO:0000269|PubMed:21119615}. Postsynaptic density
CC       {ECO:0000269|PubMed:21119615}. Synaptic cell membrane
CC       {ECO:0000269|PubMed:21119615}. Cytoplasmic vesicle, secretory vesicle,
CC       synaptic vesicle membrane {ECO:0000269|PubMed:21119615}. Cytoplasm,
CC       cytosol {ECO:0000269|PubMed:15024004, ECO:0000269|PubMed:21119615}.
CC       Nucleus {ECO:0000250|UniProtKB:O75912}. Note=Excluded from inhibitory
CC       synapses (PubMed:21119615). Localization between cytoplasm and nucleus
CC       is regulated by protein kinase C (By similarity). Both in the detergent
CC       soluble and particulate fractions (PubMed:15024004).
CC       {ECO:0000250|UniProtKB:O75912, ECO:0000269|PubMed:15024004,
CC       ECO:0000269|PubMed:21119615}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000269|PubMed:15024004}. Note=Not detected in detergent soluble
CC       fraction. {ECO:0000269|PubMed:15024004}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm
CC       {ECO:0000269|PubMed:15024004}. Note=Not detected in detergent soluble
CC       fraction. {ECO:0000269|PubMed:15024004}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=rDGKi-1 {ECO:0000303|PubMed:15024004};
CC         IsoId=F1MAB7-1; Sequence=Displayed;
CC       Name=2; Synonyms=rDGKi-2 {ECO:0000303|PubMed:15024004};
CC         IsoId=F1MAB7-2; Sequence=VSP_060835, VSP_060836;
CC       Name=3; Synonyms=rDGKi-3 {ECO:0000303|PubMed:15024004};
CC         IsoId=F1MAB7-3; Sequence=VSP_060833, VSP_060834;
CC   -!- TISSUE SPECIFICITY: Specifically expressed in brain (at protein level)
CC       (PubMed:15024004, PubMed:21119615). Expressed in hippocampus,
CC       cerebellum, brain stem and spinal cord (at protein level)
CC       (PubMed:21119615). Highly expressed in hippocampus, cerebellar cortex,
CC       olfactory bulb, and olfactory tubercle and to lower extent in the
CC       cerebral cortex, caudate putamen, and thalamus. Not detected in the
CC       white matter (PubMed:15024004). Also expressed in eye
CC       (PubMed:15024004). {ECO:0000269|PubMed:15024004,
CC       ECO:0000269|PubMed:21119615}.
CC   -!- TISSUE SPECIFICITY: [Isoform 1]: Major isoform in brain (at protein
CC       level). {ECO:0000269|PubMed:15024004}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Minor isoform in brain (at protein
CC       level). {ECO:0000269|PubMed:15024004}.
CC   -!- TISSUE SPECIFICITY: [Isoform 3]: Expressed in brain (at protein level).
CC       {ECO:0000269|PubMed:15024004}.
CC   -!- DEVELOPMENTAL STAGE: Expression gradually increases in the first weeks
CC       after birth (at protein level). {ECO:0000269|PubMed:21119615}.
CC   -!- SIMILARITY: Belongs to the eukaryotic diacylglycerol kinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB058962; BAC66854.1; -; mRNA.
DR   EMBL; AB058963; BAC66855.1; -; mRNA.
DR   EMBL; AB058964; BAC66856.1; -; mRNA.
DR   EMBL; AABR07060249; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07060250; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07060251; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07060252; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07060253; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07060254; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07060255; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_942077.2; NM_198782.2. [F1MAB7-1]
DR   AlphaFoldDB; F1MAB7; -.
DR   SMR; F1MAB7; -.
DR   IntAct; F1MAB7; 8.
DR   MINT; F1MAB7; -.
DR   STRING; 10116.ENSRNOP00000034571; -.
DR   iPTMnet; F1MAB7; -.
DR   PhosphoSitePlus; F1MAB7; -.
DR   PaxDb; 10116-ENSRNOP00000034571; -.
DR   Ensembl; ENSRNOT00000033268.5; ENSRNOP00000034571.3; ENSRNOG00000026705.6. [F1MAB7-1]
DR   Ensembl; ENSRNOT00055051861; ENSRNOP00055042798; ENSRNOG00055029887. [F1MAB7-1]
DR   Ensembl; ENSRNOT00060043095; ENSRNOP00060035660; ENSRNOG00060024590. [F1MAB7-1]
DR   Ensembl; ENSRNOT00065027687; ENSRNOP00065021808; ENSRNOG00065016585. [F1MAB7-1]
DR   GeneID; 688705; -.
DR   KEGG; rno:688705; -.
DR   AGR; RGD:735049; -.
DR   CTD; 9162; -.
DR   RGD; 735049; Dgki.
DR   eggNOG; KOG0782; Eukaryota.
DR   GeneTree; ENSGT00940000158094; -.
DR   HOGENOM; CLU_003770_4_0_1; -.
DR   InParanoid; F1MAB7; -.
DR   OrthoDB; 4642163at2759; -.
DR   TreeFam; TF312817; -.
DR   Reactome; R-RNO-114508; Effects of PIP2 hydrolysis.
DR   UniPathway; UPA00230; -.
DR   PRO; PR:F1MAB7; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000026705; Expressed in frontal cortex and 9 other cell types or tissues.
DR   ExpressionAtlas; F1MAB7; baseline and differential.
DR   GO; GO:0043679; C:axon terminus; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0043197; C:dendritic spine; ISO:RGD.
DR   GO; GO:0060076; C:excitatory synapse; IDA:MGI.
DR   GO; GO:0099147; C:extrinsic component of postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0098891; C:extrinsic component of presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0032045; C:guanyl-nucleotide exchange factor complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:MGI.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0048786; C:presynaptic active zone; IDA:MGI.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IDA:MGI.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:MGI.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004143; F:ATP-dependent diacylglycerol kinase activity; IDA:RGD.
DR   GO; GO:0005095; F:GTPase inhibitor activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031267; F:small GTPase binding; ISO:RGD.
DR   GO; GO:0046339; P:diacylglycerol metabolic process; IDA:UniProtKB.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0046959; P:habituation; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0046834; P:lipid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007269; P:neurotransmitter secretion; ISO:RGD.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; ISO:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISO:RGD.
DR   GO; GO:1900452; P:regulation of long-term synaptic depression; ISO:RGD.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; ISO:RGD.
DR   CDD; cd20850; C1_DGKiota_rpt1; 1.
DR   CDD; cd20896; C1_DGKiota_rpt2; 1.
DR   Gene3D; 2.60.200.40; -; 1.
DR   Gene3D; 3.30.60.20; -; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR017438; ATP-NAD_kinase_N.
DR   InterPro; IPR047486; C1_DGKiota_rpt1.
DR   InterPro; IPR047487; C1_DGKiota_rpt2.
DR   InterPro; IPR037607; DGK.
DR   InterPro; IPR000756; Diacylglycerol_kin_accessory.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   PANTHER; PTHR11255; DIACYLGLYCEROL KINASE; 1.
DR   PANTHER; PTHR11255:SF92; DIACYLGLYCEROL KINASE IOTA; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00609; DAGK_acc; 1.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   SMART; SM00248; ANK; 2.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00045; DAGKa; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF111331; NAD kinase/diacylglycerol kinase-like; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
DR   PROSITE; PS50146; DAGK; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ANK repeat; ATP-binding; Cell membrane;
KW   Cell projection; Coiled coil; Cytoplasm; Cytoplasmic vesicle; Kinase;
KW   Lipid metabolism; Membrane; Metal-binding; Nucleotide-binding; Nucleus;
KW   Reference proteome; Repeat; Synapse; Transferase; Zinc; Zinc-finger.
FT   CHAIN           1..1050
FT                   /note="Diacylglycerol kinase iota"
FT                   /id="PRO_0000451699"
FT   DOMAIN          367..502
FT                   /note="DAGKc"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   REPEAT          943..972
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          979..1008
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         172..227
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         245..304
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          52..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          325..356
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1048..1050
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000269|PubMed:21119615"
FT   COMPBIAS        57..73
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        328..344
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         583..591
FT                   /note="CDGTDLTPK -> LSWMRLSDS (in isoform 3)"
FT                   /id="VSP_060833"
FT   VAR_SEQ         592..1050
FT                   /note="Missing (in isoform 3)"
FT                   /id="VSP_060834"
FT   VAR_SEQ         824..840
FT                   /note="EHLHFVMEISHDEIFIL -> ACFSPLGTFALCDGDFS (in isoform
FT                   2)"
FT                   /id="VSP_060835"
FT   VAR_SEQ         841..1050
FT                   /note="Missing (in isoform 2)"
FT                   /id="VSP_060836"
FT   CONFLICT        156
FT                   /note="K -> I (in Ref. 1; BAC66854/BAC66856/BAC66855)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        170
FT                   /note="N -> I (in Ref. 1; BAC66854/BAC66856/BAC66855)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        359
FT                   /note="F -> L (in Ref. 1; BAC66854/BAC66856/BAC66855)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        594
FT                   /note="D -> E (in Ref. 1; BAC66854/BAC66855)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1050 AA;  115894 MW;  AD2B51EB74838255 CRC64;
     MDAAGRGCHL LPLPAARGPA RAPAASSALS PAGLCSGTAS ASSAAAGAVA MNPSSSAGEE
     RGATGGSSSS GSGAGSCCLG AEGGVDPRGA GAAAAAALEE PAAAGQKEKE EALEEKLRDL
     TFRKQVSYRK AISRTGLQHL APAHPLGLPV ANGPAKEPRA TLDWSENAVN GEHLWLETNV
     SGDLCYLGEE NCQVRFAKSA LRRKCAVCKI VVHTACIEQL EKINFRCKPT FREGGSRSPR
     ENFVRHHWVH RRRQEGKCKQ CGKGFQQKFS FHSKEIVAIS CSWCKQAFHN KVTCFMLHHI
     EEPCSLGAHA AVIVPPTWII KVKKPQNSLK ASNRKKKRTS FKRKASKRGT EQENKGRPFV
     IKPISSPLMK PLLVFVNPKS GGNQGTKVLQ MFMWYLNPRQ VFDLSQEGPK DALELYRKVP
     NLRILACGGD GTVGWILSIL DELQLSPQPP VGVLPLGTGN DLARTLNWGG GYTDEPVSKI
     LCQVEDGTIV QLDRWNLHVE RNPDLPPEEL EDGVCKLPLN VFNNYFSLGF DAHVTLEFHE
     SREANPEKFN SRFRNKMFYA GAAFSDFLQR SSRDLSKHVK VVCDGTDLTP KIQDLKFQCI
     VFLNIPRYCA GTMPWGNPGD HHDFEPQRHD DGYIEVIGFT MASLAALQVG GHGERLHQCR
     EVMLLTYKSI PMQVDGEPCR LAPAMIRISL RNQANMVQKS KRRTSMPLLN DPQSVPDRLR
     IRVNKISLQD YEGLHYDKEK LREASIPLGI LVVRGDCDLE TCRMYIDRLQ EDLQSVSSGS
     QRVHYQDQET SFPRAISAQR LSPRWCFLDA TSADRFYRID RSQEHLHFVM EISHDEIFIL
     DPDMVVSQQA GTPPGMPDLV VEQASGLSDW WNPALRKRML SDSGMITPHY EDSDLKDFSH
     SRVLQSPVSS EDHAILQAVI TGDLMKLMES YKNGGSLLIQ GPGHCSLLHY AAKTGNGEIV
     KYILDHGPAE LLDMADSETG ETALHKAACQ RNRAVCQLLV DAGASLRQTD SKGKTPQERA
     QQAGDPDLAA YLESRQNYKI IGHEDLETAV
//
